ClinicalTrials.gg
RecruitingNCT07739225PCE-HFSUpdated Sep 9, 2026

Patient-Centered Education After Hip Fracture Surgery

An interventional study of Structured Patient-Centered Educational Program. in Hip Fractures, sponsored by Assiut University. Recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 12 studies in Hip Fractures by Assiut University — 7 open to participants now, 7 under way, 3 of them phase 3. Hip Fractures · Assiut University.

Started
2026
with 1 other
No phase
3 of 12
2 open now
Registered
10th of 12
by date

Among the 12 studies in Hip Fractures by Assiut University, this one is one of 2 that started in 2026, is one of 3 with no phase, and was the 10th registered.

Hip Fractures

842 studies on the registry are indexed under Hip Fractures; 165 are open to participants now.

Browse Hip Fractures studies →

Open to participants now

7 of the 12 studies in Hip Fractures by Assiut University are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Hip Fractures by Assiut University, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effect of a structured patient-centered educational program on postoperative outcomes among patients undergoing hip fracture surgery. Participants will be randomly assigned to either an intervention group receiving the educational program in addition to routine care or a control group receiving routine care only. The study will assess whether the educational program improves postoperative recovery, functional independence, and pain outcomes following hip fracture surgery.

Read the detailed description

Hip fracture is a major cause of disability, functional decline, and increased healthcare utilization among older adults. This study is a parallel-group randomized controlled trial conducted at the Orthopedic Department and Orthopedic Outpatient Clinics of Qena University Hospital. Participants will be randomly allocated in a 1:1 ratio to either an intervention group receiving a structured patient-centered educational program in addition to routine postoperative care or a control group receiving routine postoperative care alone. Randomization will be performed using computer-generated random numbers with allocation concealment using sealed opaque envelopes, and outcome assessment will be conducted by a blinded assessor. The educational program includes education on postoperative care, pain management, safe mobility, rehabilitation exercises, activities of daily living, prevention of postoperative complications, and discharge planning, supported by an illustrated educational booklet. Participants will be followed from the preoperative assessment through hospital discharge and scheduled postoperative follow-up visits.

03

Conditions studied

  • Hip Fractures

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing hip fracture surgery.
  • Medically stable and able to participate in the educational program.
  • Able to understand study instructions and provide written .

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment that prevents participation (e.g., dementia).
  • Severe comorbidities that significantly limit mobility.
  • Discharged before completion of the educational program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Participants in this group will receive a structured patient-centered educational program in addition to routine postoperative care.

    Behavioral: Structured Patient-Centered Educational Program.

  • No intervention
    Control Group

    Participants in this group will receive routine postoperative care only.

Interventions

  • BehavioralStructured Patient-Centered Educational Program.

    A structured educational program focusing on postoperative care, pain management, rehabilitation exercises, safe mobility, prevention of complications, and activities of daily living, supported by an illustrated educational booklet.

06

What researchers measure

Primary outcomes

  1. Functional Independence Measure (FIM) Total Score.

    The Functional Independence Measure (FIM) will be used to assess functional independence following hip fracture surgery. The FIM consists of 18 items with a total score ranging from 18 to 126. Higher scores indicate greater functional independence and better postoperative functional outcomes.

    Time frame: Baseline (preoperative), at hospital discharge (assessed up to 4 days after surgery), 1 month after surgery, and 3 months after surgery.

Secondary outcomes

  1. Visual Analog Scale (VAS) Pain Score.

    Pain intensity will be assessed using the Visual Analog Scale (VAS). The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.

    Time frame: Baseline (preoperative), at hospital discharge (assessed up to 4 days after surgery), 1 month after surgery, and 3 months after surgery.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared with other researchers. Participant data will remain confidential and will only be used for the purposes of this study in accordance with ethical research principles and institutional regulations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Feb 2027, 5 months after the start.

Of 221 non-industry interventional studies with no phase under Hip Fractures, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 55. This study's planned 5 months is below that.

Counting every sponsor, half of 237 studies reached it within 29 months; a quarter within 10 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2026
First posted
Jul 31, 2026
StartActual
Sep 5, 2026
Primary completionEst.
Feb 5, 2027
CompletionEst.
Dec 2027
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07739225
Lead sponsor
Assiut University
Responsible party
Asmaa Edrees Fathallah Edrees (Doctoral Researcher, Faculty of Nursing, Assiut University, Assiut University) — Principal investigator
First posted
Jul 31, 2026
Start date
Sep 5, 2026
Primary completion
Feb 5, 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Aamaa Edrees Fathallah, MSCN
Contact
asmaa.edress0986@nursing.aun.edu.eg
+21020910362
Samia Youssef Sayed, Prof
study chair · Faculty of Nursing, Assiut University
Rasha Ali Ahmed Abdelmowla, Prof
study chair · Faculty of Nursing, Assiut University
Hamdy Ahmed Hussein Tammam, Asst. Prof
study chair · Faculty of Medicine, South Valley University, Qena

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion